Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice

Abstract

Anti-VEGF agents may be able to improve survival of patients with glioblastoma, even without inhibiting tumor growth.